The main ground for the Financial Supervisory Service’s allegations that Samsung BioLogics had committed accounting fraud was the company’s conversion in 2015 of the status of Samsung Bioepis from a subsidiary to an affiliate. But the FSS actually argued during its special audit of Samsung BioLogics